Cover Image

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Daniel Backenroth, Ting Ye
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment
by: Jiren Sun, et al.
Published: (2025)

Regression Adjustment in Covariate‐Adaptive Randomized Experiments With Missing Covariates
by: Wanjia Fu, et al.
Published: (2025)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
by: Xinran Huang, et al.
Published: (2024)

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
by: Jingya Gao, et al.
Published: (2024)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
by: Hyejung Jung, et al.
Published: (2026)

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints
by: Ryota Ishii, et al.
Published: (2025)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
by: Adrien Ollier, et al.
Published: (2025)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
by: Xiaotian Chen, et al.
Published: (2025)

Sample Size Adjustment in Sequential Multiple Assignment Randomized Trials
by: Liwen Wu, et al.
Published: (2025)

Dynamic Borrowing From Historical Controls via the Synthetic Prior With Covariates in Randomized Clinical Trials
by: Daniel E. Schwartz, et al.
Published: (2026)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
by: Alessandra Serra, et al.
Published: (2025)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
by: Jingyan Fu, et al.
Published: (2025)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
by: David S. Robertson, et al.
Published: (2025)

Efficient Risk Assessment of Time‐to‐Event Targets With Adaptive Information Transfer
by: Jie Ding, et al.
Published: (2024)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
by: Zhiwei Zhang, et al.
Published: (2025)

Adaptive Weight Selection for Time‐To‐Event Data Under Non‐Proportional Hazards
by: Moritz Fabian Danzer, et al.
Published: (2025)

Sequential Parallel Comparison Design for Assessing Induction, Maintenance, Long‐Term, and Other Treatment Effects on a Binary Endpoint
by: Hui Quan, et al.
Published: (2026)

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards
by: Florian Klinglmüller, et al.
Published: (2025)

Dual‐Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time‐to‐Event Group Sequential Trials
by: Marco Ratta, et al.
Published: (2026)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
by: Huiman Barnhart, et al.
Published: (2025)

A Note on the Sample Size Formula for a Win Ratio Endpoint
by: Se Yoon Lee
Published: (2025)

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin
by: Guangyong Zou, et al.
Published: (2024)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
by: Ethan Ashby, et al.
Published: (2025)

Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
by: Fei Gao, et al.
Published: (2025)

Multivariate Adjustments for Average Equivalence Testing
by: Younes Boulaguiem, et al.
Published: (2025)

The Design of Large‐Scale Plasma Donation Trials
by: Kecheng Li, et al.
Published: (2025)

Two‐Stage Double‐Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region
by: Jiashan He, et al.
Published: (2026)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
by: Yunyi Liu, et al.
Published: (2026)

Analysis of Covariance in General Factorial Designs Through Multiple Contrast Tests Under Variance Heteroscedasticity
by: Matthias Becher, et al.
Published: (2025)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
by: Maria Vittoria Chiaruttini, et al.
Published: (2026)

Cluster‐Level Analyses to Estimate a Risk Difference in a Cluster Randomized Trial With Confounding Individual‐Level Covariates: A Simulation Study
by: Jules Antoine Pereira Macedo, et al.
Published: (2025)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
by: Gi‐Ming Wang, et al.
Published: (2026)

Preference‐Informed Cluster Randomized Design for Pragmatic Clinical Trials
by: Yuwei Cheng, et al.
Published: (2026)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
by: Shu Jiang, et al.
Published: (2025)

Balancing Events, Not Patients, Maximizes Power of the Logrank Test: And Other Insights on Unequal Randomization in Survival Trials
by: Godwin Yung, et al.
Published: (2025)

Robust Heterogeneity Adjustment for Gaussian Graphical Model With Latent Variables
by: Linxi Li, et al.
Published: (2026)

Covariate Balancing With Measurement Error
by: Xialing Wen, et al.
Published: (2025)

Network Meta‐Analysis With Individual Participant‐Level Data of Time‐to‐Event Outcomes Using Cox Regression
by: Kaiyuan Hua, et al.
Published: (2025)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
by: Yingjie Qiu, et al.
Published: (2026)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
by: Yuan Li, et al.
Published: (2025)